Evidence map›Paper›PMID 41363079›Full record

ArticleAnnals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc2026

Acute Reduction in Blood Flow in the Right Coronary Artery After PCI Facilitates Pacemaker-Induced Ventricular Fibrillation.

Bo Wu, Yaqin Chen, Jianjun Tang, Jia He

Abstract readCase Reports
In one paragraph

Article in Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Acute Reduction in Blood Flow in the Right Coronary Artery After PCI Facilitates Pacemaker-Induced Ventricular Fibrillation.Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Bo WuNational Clinical Research Center for Metabolic Diseases, Hunan Key Lab for Metabolic Bone Diseases and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, China.
Yaqin ChenDepartment of Cardiology, The Second Xiangya Hospital of Central South University, Changsha, China.
Jianjun TangDepartment of Cardiology, The Second Xiangya Hospital of Central South University, Changsha, China.
Jia HeDepartment of Cardiology, The Second Xiangya Hospital of Central South University, Changsha, China.ORCID 0000-0003-1501-1370

Funding

Provincial Natural Science Foundation of Hunan 2022JJ40672
6 · The paper itself

Abstract

Asynchronous pacing itself does not directly lead to the development of malignant ventricular arrhythmias. However, acute myocardial ischemia caused by acute reduction in coronary blood flow can result in a "vulnerable myocardium" and simultaneously impair pacemaker sensing function. Such a scenario may give rise to unintended asynchronous pacing, which can act as a trigger for malignant ventricular arrhythmias. We present a case illustrating how ischemia-induced pacemaker sensing failure contributed to life-threatening ventricular arrhythmias, highlighting the critical interplay between myocardial perfusion status and pacemaker behavior.

Indexed as

Coronary CirculationPacemaker, ArtificialPercutaneous Coronary InterventionVentricular FibrillationAgedCoronary AngiographyCoronary VesselsElectrocardiographyHumansMaleasynchronous pacingno‐reflow phenomenonpacemaker‐induced ventricular fibrillation

Identifiers

PMID41363079
PMCPMC12686961

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.